Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $51.6300 (1.04%) ($51.6300 - $51.6300) on Tue. Jan. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.5% (three month average) | RSI | 36 | Latest Price | $51.6300(1.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(41%) IBB(40%) IFRA(39%) IWO(36%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -1.25% in a week (0% probabilities). VXX(-16%) VIXM(-13%) UUP(-11%) IGOV(-10%) GLD(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.25% (StdDev 2.5%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $52.41 | 5 Day Moving Average | $51.85(-0.42%) | 10 Day Moving Average | $51.76(-0.25%) | 20 Day Moving Average | $52.41(-1.49%) | To recent high | -13% | To recent low | 12.8% | Market Cap | $7.056b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |